Publications by authors named "Kyle Vaccaro"

Claim this Profile
U
Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphoma.
Juliano Ribeiro, Carlota Pagès-Geli, Anna Meglan, Jose Velarde, Jasmine Blandin, Kyle Vaccaro

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD47 predominates over CD24 as a macrophage immune checkpoint in cancer.
Juliet Allen, Anna Meglan, Kyle Vaccaro, José Velarde, Victor Chen

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, Asaf Maoz, Sarah Reeves

J Clin Invest· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis.
Vaishnavi V Phadnis, Jamie Snider, Venkateshwari Varadharajan, Iyappan Ramachandiran, Amy A Deik, Kyle D Vaccaro

Cell Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction.
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, Asaf Maoz, Sarah Reeves

bioRxiv· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concise Review: Mesenchymal Stem Cells Derived from Human Pluripotent Cells, an Unlimited and Quality-Controllable Source for Therapeutic Applications.
Bin Jiang, Li Yan, Xiaoyan Wang, Enqin Li, Kyle Murphy, Kyle Vaccaro

Stem Cells· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis